HEALTH● LOWAug 5 · Aug 5, 2026, 4:31 PM
United Therapeutics anticipates potential 2027 approvals for ralinepag and Tyvaso IPF while holding 2026 revenue outlook unchanged
Seeking Alpha Tech
United Therapeutics expects potential 2027 approvals for ralinepag and Tyvaso IPF while maintaining its 2026 revenue outlook. This provides an update on the company's product pipeline and financial projections.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h ago Would have dropped dead : women heart health lackingtheadvocate.com.au · AustraliaHEALTH1h agoDiphtheria: Plateau makes face masks compulsory on metro busesVanguard NigeriaHEALTH1h agoWHO coordinates expansion of Ebola treatment centre in DR Congo as death toll climbsAfricanews [en]HEALTH1h agoOklahoma City VA highlights veteran suicide prevention resourceskoco.com · United States